Healthcare AI consulting: what to expect and what to ask
Short answer: healthcare AI consulting is worth buying when the adviser has shipped a clinical system and can tell you where it broke. The distinguishing requirement in this sector is not model quality, it is that the system must surface uncertainty rather than produce a confident wrong answer, and that constraint reaches back into architecture, evaluation and workflow design.
What healthcare AI consulting should actually cover
Four things. If an engagement does not touch all four, it is general AI consulting with a healthcare client.
Where PHI is allowed to sit. Which components may see protected health information, how long it persists, what leaves your boundary, and what must be reconstructable afterwards. This is an architecture question decided in week one, not a compliance review at the end.
What the system does when it is unsure. Confidence scoring on every extracted or generated field, an escalation path, and a clinician review step before anything is filed. In healthcare a confident wrong answer is worse than no answer, and the architecture has to reflect that.
How accuracy is measured. Against a labelled sample of your own encounters and documents, at field level, with both error directions tracked separately. Not a vendor’s benchmark on their data.
Where it fits the clinical workflow. A system that produces excellent output nobody uses has failed. The question is what a clinician does differently on Tuesday.
The questions that sort advisers
What have you put into production in a clinical setting, and who operates it now? Ask what broke and what changed as a result.
How did you handle the PHI boundary? A specific answer names components and data flows. A vague one means they signed an agreement and hoped.
What does your system do with a low-confidence field? If the answer is that accuracy is very high, they have not run one of these.
Have you written into a chart, or only produced text? Writing into the record is the line between a demo and a deployed system, and it is mostly an integration and governance problem rather than an AI one.
When would you tell me to buy a product instead? In this sector that answer is often yes. If your documentation burden is a standard note and your EHR is well supported by an ambient scribe vendor, buy it.
Where these projects actually stall
Rarely on the model. Almost always on one of three things.
Integration access. The EHR is administered by a party whose priorities are not yours, and their queue becomes your timeline. Establish early whether you can write to the chart or only read from it.
Evaluation data. You need real encounters with known correct output, and getting them cleared for use takes longer than building the pipeline. Start that conversation in week one.
Clinical sign-off. Somebody senior has to accept responsibility for what the system produces. If that person is not identified at the start, the project finishes and then sits unused.
What the work looks like in practice
Documentation is the most common starting point, because it is where clinician time disappears and the value is measurable.
For a healthcare client we built an ambient scribe that turns a consultation into completed paperwork rather than a transcript, auto-filling more than ten mandatory forms per encounter with per-field confidence scoring for review. Separately, a clinical orchestrator routes natural-language requests to specialised sub-agents for notes, eligibility and records retrieval, and carries zero citation hallucinations because answers are assembled from retrieved passages rather than instructed not to invent. Both are written up in the case studies.
Those are the kind of specifics to demand. Not a capability list.
Buy the product where the product fits
Worth stating plainly, because a consultancy has an incentive not to.
If you need a standard clinical note, your EHR is well supported, and your volumes are moderate, an ambient scribe product will serve you better and faster than anything custom. Building is right when your burden is structured forms rather than prose, when your EHR is not meaningfully supported, when data residency rules out the vendor, or when per-clinician pricing has become your dominant cost.
The compliance questions to settle first
Three answers determine the architecture, and answering them after a prototype exists is how healthcare projects stall in security review.
Where may protected health information travel? That draws a boundary through the system: which components sit inside it, what is de-identified on the way out, and whether a hosted model provider will sign a business associate agreement. A provider that will not has to sit outside the boundary, which means de-identified input or self-hosting.
Is this a medical device? Software informing a clinical decision may be regulated, and the answer depends on the claim you make rather than the technology. Summarising what a clinician already has is different from suggesting what they should do.
What has to be reconstructable, and for how long? Anything reaching a chart needs its inputs, model version and the policy in force retained for the life of the record.
A consultant who does not raise all three in the first meeting has not delivered in this sector.
What the engagement should produce
A feasibility assessment against your real data rather than a description of it, including what the data is actually like: duplicate patients, codes entered for billing rather than accuracy, and the information that lives only in free text.
An integration assessment naming which systems hold what, what your EHR vendor will actually give you, at which licence tier, and how long approval takes. This is the item that most often changes the plan.
A clinical evaluation design, agreed with your clinicians, that names what an unacceptable error looks like before anything is built. That threshold is a clinical judgement rather than a technical one.
And the arithmetic, which in healthcare includes clinician time for labelling and review as a real cost rather than an assumption.
Where budgets actually go
Not modelling. Access and integration.
Getting to the data takes months rather than weeks: vendor approval, licence tiers, security review, and a sandbox that behaves like production. Start it in week one, because the modelling work is worth nothing until it runs against real records.
Clinical validation is the second line, and it is clinician time, which is the scarcest resource in the building. Budget it explicitly. An adviser who treats retrospective chart review as free has not run one.
The takeaway
Healthcare AI consulting is worth paying for when the adviser has operated a clinical system and designs for uncertainty rather than around it. Ask what they have in production, how they handled PHI, and what happens to a low-confidence field. The answers sort the field quickly.
EpochC builds clinical AI for healthcare organisations, including AI medical scribe development and medical-records retrieval that cites its sources. See the clinical multi-agent API case study or start a project.